Further, we observed that the rate of tumor growth after OV-CXCR4-A treatment was significantly slower in WT compared with TgMISIIR-TAg-Low mice (Figure 1B; p = 0.02), which was reflected by longer survival periods (Figure 1C; median survival 69 days versus 41 days, respectively). The gene discussed is CXCR4; the disease is neoplasm.